Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Benefits of Semaglutide In this section, we will provide an overview of the benefits of semaglutide, a drug that has demonstrated safety and effectiveness in a range of indications
The results showed that subcutaneous semaglutide treatment had great beneficial effect on body weight control, with additional improvements on cardiovascular and metabolic profiles
News provided by Eli Lilly and Company May 28, 2026, 13:00 ET Phase 3 ACHIEVE results showed Foundayo, an oral GLP-1 taken without food or water restrictions, outperformed oral semaglutide and dapagliflozin in type 2 diabetes, reinforcing its potential to redefine oral incretin therapy New analyses of the ATTAIN program highlight Foundayo' s profile in patient populations central to the future of cardiometabolic care, including women at every stage of menopause Pivotal Phase 3 results showed retatrutide, a first-in-class triple receptor agonist, delivered powerful results in obesity, type 2 diabetes and other complications INDIANAPOLIS, May 28, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide), Mounjaro (tirzepatide), Foundayo (orforglipron) and retatrutide, will present new data across its cardiometabolic portfolio at the American Diabetes Association's 86th Scientific Sessions taking place June 5-8 in New Orleans
Check the math: 4 days equals 96 hours, which clears the 72-hour minimum
US$ 29.39
US$ 24.01
US$ 22.42
